ACBM — Acro Biomedical Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Acro Biomedical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.095	0.006	0	0	0.004
Net Total Accounts Receivable
Net Total Receivables	0.598	0.638	0	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.706	0.658	0.002	0.005	0.014
Net Property, Plant And Equipment	0.05	0.026	0.052	0.027	0
Other Long Term Assets
Total Assets	0.761	0.687	0.058	0.032	0.014
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.092	0.201	0.289	0.327	0.401
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.117	0.201	0.315	0.327	0.401
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	0.644	0.486	-0.257	-0.295	-0.387
Total Liabilities & Shareholders' Equity	0.761	0.687	0.058	0.032	0.014
Total Common Shares Outstanding